[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 17, 2002

Is One Selective Serotonin Reuptake Inhibitor Better Than Another?

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;287(15):1935-1938. doi:10.1001/jama.287.15.1935

To the Editor: We question the main conclusion of Dr Kroenke and colleagues1 that paroxetine, fluoxetine, and sertraline had similar efficacy for the treatment of depressive symptoms and improvement in health-related quality of life. Although there were no statistically significant differences when the measures were analyzed individually, we noticed a pattern in the outcomes that did not appear to be random.

First Page Preview View Large
First page PDF preview
First page PDF preview
×